Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
etrinabdione (EHP-101) / Emerald Health Pharmaceuticals, Aphios, Emerald Health Research
NCT04166552: Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis Jan 2023 - Mar 2023 : Interim results for systemic sclerosis	Suspended	2a	36	US, RoW	Patients will be randomized to receive EHP-101 or Placebo	Emerald Health Pharmaceuticals	Diffuse Cutaneous Systemic Sclerosis	07/24	10/24
CLAUDIA, NCT06774040: Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease	Not yet recruiting	2	30	Europe	Etribnabdione 25 mg BID, Etribnabdione 50 mg BID	VivaCell Biotechnology España	Peripheral Arterial Disease	03/27	05/27
APH1105 / Aphios
NCT03806478: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease	Not yet recruiting	2	60	NA	APH-1105, Placebo	Aphios	Dementia, Alzheimer Disease 1, Alzheimer Disease 2, Alzheimer Disease 3	09/24	12/24
APH-1104 / Aphios
No trials found
APH-1104 less potent analog / Aphios
No trials found
APH-1104 analog / Aphios
No trials found
betulinic acid nanoformulation (APH-0202) / Aphios
No trials found
APP-401 / Aphios
No trials found
APP-069 / Aphios
No trials found
betulinic acid nanoformulation (APH-0201) / Aphios
No trials found
Dermos (paclitaxel nanosomal) / Aphios
No trials found
Camposomes (camptothecin nanosomal) / Aphios
No trials found
Taxosomes (paclitaxel nanosomal) / Aphios
No trials found
Marinus / Aphios
No trials found
APP-0205 / Aphios
No trials found
APP-309 / Aphios
No trials found
nanoTHC (dronabinol) / Aphios
No trials found
NanoCanna (cannabinoid nano) / Aphios
No trials found
oral insulin (APH-0907) / Aphios
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
etrinabdione (EHP-101) / Emerald Health Pharmaceuticals, Aphios, Emerald Health Research
NCT04166552: Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis Jan 2023 - Mar 2023 : Interim results for systemic sclerosis	Suspended	2a	36	US, RoW	Patients will be randomized to receive EHP-101 or Placebo	Emerald Health Pharmaceuticals	Diffuse Cutaneous Systemic Sclerosis	07/24	10/24
CLAUDIA, NCT06774040: Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease	Not yet recruiting	2	30	Europe	Etribnabdione 25 mg BID, Etribnabdione 50 mg BID	VivaCell Biotechnology España	Peripheral Arterial Disease	03/27	05/27
APH1105 / Aphios
NCT03806478: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease	Not yet recruiting	2	60	NA	APH-1105, Placebo	Aphios	Dementia, Alzheimer Disease 1, Alzheimer Disease 2, Alzheimer Disease 3	09/24	12/24
APH-1104 / Aphios
No trials found
APH-1104 less potent analog / Aphios
No trials found
APH-1104 analog / Aphios
No trials found
betulinic acid nanoformulation (APH-0202) / Aphios
No trials found
APP-401 / Aphios
No trials found
APP-069 / Aphios
No trials found
betulinic acid nanoformulation (APH-0201) / Aphios
No trials found
Dermos (paclitaxel nanosomal) / Aphios
No trials found
Camposomes (camptothecin nanosomal) / Aphios
No trials found
Taxosomes (paclitaxel nanosomal) / Aphios
No trials found
Marinus / Aphios
No trials found
APP-0205 / Aphios
No trials found
APP-309 / Aphios
No trials found
nanoTHC (dronabinol) / Aphios
No trials found
NanoCanna (cannabinoid nano) / Aphios
No trials found
oral insulin (APH-0907) / Aphios
No trials found